In depression, one of the most common and costly brain diseases, people feel intensely and persistently sad, experience no pleasure, and lose interest in the things around them.
As a result, they have difficulty concentrating, trouble staying asleep, and a lack of appetite. They may think of committing suicide. The potential results: ruined health, devastated personal relationships, lost jobs — even death.
The National Institute of Mental Health estimates that 6 to 10 percent of Americans suffer from depression each year. In any given two-week period, about 5 percent of people are depressed. In total, 15 to 20 percent of people suffer from depression at least once in their lives.
It interferes with normal life in four-fifths of sufferers, and more than a quarter report serious difficulties in work or home life.
More than 20 percent of people with depression attempt suicide, and about a quarter of these are eventually successful. Depression also increases the risk of dying from heart disease, stroke, and other conditions.
In addition to billions in direct medical costs, researchers estimate that depression causes $44 billion in lost work productivity in the United States alone. Depression also is the leading cause of disability in the United States and worldwide.
Fortunately, neuroscientists supported by the National Institutes of Health and other funding agencies around the world are developing new, more powerful treatment options to help prevent depression or minimize its effects.
People suffering from depression now have multiple treatment options that can help reduce symptoms and prevent the likelihood of relapse. Researchers have found, for instance, that psychotherapy, or "talk therapy," can often treat depression on its own, especially in mild to moderate cases. Cognitive behavioral therapy, which focuses on identifying and changing negative ways of thinking, has shown particularly strong results. Exercise and stress management also can help improve mood.
In many cases, however, antidepressant medications, either alone or alongside therapy, are needed. The past decade has seen the development of sophisticated medications that target serotonin and norepinephrine, molecules that facilitate communication between brain cells. One popular class of drugs are the selective serotonin reuptake inhibitors, which include fluoxetine (Prozac) and sertraline (Zoloft). Serotonin and norepinephrine reuptake inhibitors, such as venlafaxine (Effexor) and duloxetine (Cymbalta), also are widely used.
Medications can have serious side effects and may need several weeks to take effect. They also can be idiosyncratic. Many people who struggle with one drug may find relief after switching to something else or by taking a combination of drugs. In some cases, older classes of antidepressants, such as tricyclics and monoamine oxidase inhibitors may be the best choices. Currently, finding the right treatment is largely trial and error.
Courtesy: Society for Neuroscience